(Q71763523)
Statements
A phase 2 study with epirubicin as second-line treatment of patients with advanced epithelial ovarian cancer (English)
Havsteen H
Bertelsen K
Gadeberg CC
Jacobsen A
Kamby C
Sandberg E
1 November 1996
scientific article published on 01 November 1996